MY187125A - Hydrogel formulation for wound healing and/or treatment - Google Patents

Hydrogel formulation for wound healing and/or treatment

Info

Publication number
MY187125A
MY187125A MYPI2014003164A MYPI2014003164A MY187125A MY 187125 A MY187125 A MY 187125A MY PI2014003164 A MYPI2014003164 A MY PI2014003164A MY PI2014003164 A MYPI2014003164 A MY PI2014003164A MY 187125 A MY187125 A MY 187125A
Authority
MY
Malaysia
Prior art keywords
mixture
hydrogel formulation
hydrogel
polymer
wound
Prior art date
Application number
MYPI2014003164A
Inventor
Mohd Yunus Rosli
Gupta Arun
Kumaran Priyaah
Original Assignee
Univ Malaysia Pahang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Malaysia Pahang filed Critical Univ Malaysia Pahang
Priority to MYPI2014003164A priority Critical patent/MY187125A/en
Publication of MY187125A publication Critical patent/MY187125A/en

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

The present invention described a method for preparing a hydrogel formulation, said method comprising the following steps: (a) forming a mixture of 20-40% (w/w%) chicken feather keratin in polymer solution; (b) pouring the resulting mixture into a dish to a desired thickness; and (c) subjecting the mixture to repeated freezing and thawing cycle until a hydrogel is formed, wherein the polymer solution comprises a mixture of synthetic polymer and a bio-polymer, and wherein each freezing is carried out at -83C for 1 hour followed by thawing at room temperature for 1 hour. The hydrogel formulation, when used as a wound dressing, renders high absorption, contours to a wound site and maintains the wound in a moist state to promote healing thereof.
MYPI2014003164A 2014-11-13 2014-11-13 Hydrogel formulation for wound healing and/or treatment MY187125A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2014003164A MY187125A (en) 2014-11-13 2014-11-13 Hydrogel formulation for wound healing and/or treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2014003164A MY187125A (en) 2014-11-13 2014-11-13 Hydrogel formulation for wound healing and/or treatment

Publications (1)

Publication Number Publication Date
MY187125A true MY187125A (en) 2021-09-02

Family

ID=81329890

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2014003164A MY187125A (en) 2014-11-13 2014-11-13 Hydrogel formulation for wound healing and/or treatment

Country Status (1)

Country Link
MY (1) MY187125A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114796620A (en) * 2022-04-24 2022-07-29 广东顺德工业设计研究院(广东顺德创新设计研究院) Interpenetrating network hydrogel used as medical implant material and preparation method and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114796620A (en) * 2022-04-24 2022-07-29 广东顺德工业设计研究院(广东顺德创新设计研究院) Interpenetrating network hydrogel used as medical implant material and preparation method and application thereof
CN114796620B (en) * 2022-04-24 2023-09-29 广东顺德工业设计研究院(广东顺德创新设计研究院) Interpenetrating network hydrogel used as medical implant material and preparation method and application thereof

Similar Documents

Publication Publication Date Title
HRP20200431T1 (en) Polymer based hydrogel
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
BR112016011065A8 (en) crystalline compound, pharmaceutical composition, dosage form, method for treating anemia
EP3928800A3 (en) Dry powder composition comprising long-chain rna
GB2535117A (en) A ready to use biodegradable and biocompatable device and a method of preparation thereof
PH12015502535A1 (en) Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
BR112016021130A2 (en) THERAPEUTIC NANOPARTICLES, PHARMACEUTICAL COMPOSITION INCLUDING THE SAID NANOPARTICLES, PROCESS FOR THE PREPARATION AND USE THEREOF
MX353942B (en) Post-procedure skin care systems, compositions, and methods of use thereof.
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
HRP20210699T1 (en) A modified collagen
WO2019040106A3 (en) Compounds, salts thereof and their use in the treatment of diseases
PH12018501362A1 (en) Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists
EP3312151A4 (en) Oxidation-induced self-healing ceramic composition containing healing activator, method for producing same, use of same, and method for enhancing functionality of oxidation-induced self-healing ceramic composition
EA201592073A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING COLLAGEN AND SODIUM HYALURONATE
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
WO2015026992A3 (en) Hair treatment methods and kits thereof
TN2018000188A1 (en) Isoindole compounds
MX2015016057A (en) Stabilized hypochlorous acid solution and use thereof.
BR112016009178A8 (en) method of preparing a tissue product, and, using a tissue product
MX2017004760A (en) Heat-sterilized formulation comprising chitosan and process of preparation thereof.
EP3197443A4 (en) Compositions and methods for enhancing hair growth, promoting skin regeneration, and wound healing
CA2922375C (en) Alpha-tea salt forms: compositions and uses for treating disease
WO2014165513A3 (en) Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof
WO2019040105A3 (en) Compounds, salts thereof and their use in the treatment of diseases
EA201591704A1 (en) NEW SUSTAINABLE SALTS OF PENTADECEPEPTIDE, METHOD OF THEIR PRODUCTION, THEIR APPLICATION IN THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION IN THERAPY